A new study presents a non-invasive model combining serum KL-6 levels and lung ultrasound B-lines to screen and predict interstitial lung disease in patients with idiopathic inflammatory myopathy. This approach could enhance early detection and management of lung complications in this patient population.
serum kl 6 and lung ultrasound b lines a combined non invasive model for screening and predicting interstitial lung disease in idiopathic inflammatory myopathy
Original title: “Serum KL-6 and lung ultrasound B-lines: a combined non-invasive model for screening and predicting interstitial lung disease in idiopathic inflammatory myopathy.”